Skip to main content
Elsevier

Journals in Toxicology

Elsevier's Toxicology collection provides essential insights for researchers and scientists into mitigating the adverse effects of contaminants on organisms, covering research, analysis, risk assessment, detection, prevention, diagnosis, and treatment of toxic exposure. Including toxicity testing, environmental toxicology it offers valuable knowledge for addressing public health and safety challenges by examining the adverse effects of contaminants on human health, animals, and the environment.

  • Toxicology in Vitro

    • ISSN: 0887-2333
    Affiliated with the American Association for Cellular and Computational Toxicology and the European Society for Toxicology in Vitro.Toxicology in Vitro publishes original research papers, reviews and workshop reports focusing on the application and use of in vitro and in silico systems for toxicological evaluations (collectively described as New Approach Methodologies (NAM)). This includes the utilisation or the development of NAMs for assessing the potential adverse effects of chemicals for human safety assessment. In vitro techniques include primary cells, tissue slices, cell lines and stem cells (adult, embryonic and induced Pluripotent cells) or subcellular preparations thereof. Our journal strongly supports the Reduction, Refinement and Replacement (3R) of animals in toxicology evaluations.This is a wide topic and thus we have certain preferences including:Developmen... of in vitro techniques and their application to research and regulatory use (i.e. 3R principle.Mechanisti... underpinning of data.Ability to translate outcome to human safety assessment.We strongly encourage :The use of normal (non-transformed) human cells (where appropriate).Reporti... the Short Tandem Repeat (STR) profile of the cells used (especially when cells have been provided as a gift or generated in house).Free access to raw (or primary) data.Appropriate model characterisation.The use (or reduction) of animal free components, including serum. [Especially when the system was already developed under such conditions, such as the HK-2 cell line].Attention to detailed methodology and appropriate statistics. [Readers need to know how you did the experiment, how many times, how many replicates etc?]Reporting the source of the compounded tested, catalogue no. and lot no. Where the chemical has been purified or synthesised a full analytical report is expected.Quantificat... of compounds in exposure medium and/or cells over time (biokinetics).We do not accept solely in vivo investigations and rarely accept animal in vivo, in vitro hybrid papers, except where the animal data was critical in the interpretation or validation of the in vitro data (and not merely confirmatory).We generally discourage investigations relating:Unidentifie... mixtures - for example in plant extracts.Solely pharmacological investigations (e.g. demonstrating your chemical kills cancer cells in vitro is not generally acceptable).Use of non-human cells when human equivalents exist and are available.The lack of adherence to established protocols, without direct explanation.Reportin... cytotoxicity alone, with no mechanistic underpinning and/or no estimation of chemical exposure.
    Subscriptions

  • Legal Medicine

    • ISSN: 1344-6223
    Official Journal of the Japanese Society of Legal Medicine.Legal Medicine provides an international forum for the publication of original articles, reviews and correspondence on subjects that cover practical and theoretical areas of interest relating to the wide range of legal medicine. Subjects covered include forensic pathology, toxicology, odontology, anthropology, criminalistics, immunochemistry, hemogenetics and forensic aspects of biological science with emphasis on DNA analysis and molecular biology. Submissions dealing with medicolegal problems such as malpractice, insurance, child abuse or ethics in medical practice are also accepted.
    Subscriptions

  • Toxicology and Applied Pharmacology

    • ISSN: 0041-008X
    Toxicology and Applied Pharmacology publishes original scientific research of relevance to animals or humans pertaining to the action of chemicals, drugs, or chemically-defined natural products.Regular articles address mechanistic approaches to physiological, pharmacologic, biochemical, cellular, or molecular understanding of toxicologic/patholog... lesions and to methods used to describe these responses. Safety Science articles address outstanding state-of-the-art preclinical and human translational characterization of drug and chemical safety employing cutting-edge science. Highly significant Regulatory Safety Science articles will also be considered in this category. Papers concerned with alternatives to the use of experimental animals are encouraged.Short articles report on high impact studies of broad interest to readers of TAAP that would benefit from rapid publication. These articles should contain no more than a combined total of four figures and tables. Authors should include in their cover letter the justification for consideration of their manuscript as a short article.TAAP also issues a standing call for outstanding Invited Review Articles. Potential authors should contact the Editor-In-Chief and complete an Invited Review Proposal Form before preparing or submitting their Review Article.
    Subscriptions

  • NeuroToxicology

    • ISSN: 0161-813X
    Affiliated with the International Neurotoxicology AssociationNeuroToxi... specializes in publishing peer-reviewed original research papers describing the effects of toxic substances on the nervous system across the lifespan as determined in humans and/or experimental models (in vivo, in vitro, in silico). The Journal welcomes papers dealing with the neurotoxic effects of occupationally and environmentally relevant exposures to agents (chemical, physical, biological, pharmacological or naturally occurring), singly or in mixtures, including complex mixtures, such as air pollution. Papers describing neurotoxic outcomes associated with natural disasters, industrial accidents, and terrorist attacks are also welcome.Experimental (animal, in vitro, in silico) papers focused on the neurotoxic effects of undefined commercial formulas (i.e., pesticide formulations) will be considered only if the authors report the chemical composition of the formulation and/or determine whether neurotoxic effects are due to the active chemical ingredient(s), carrier, or combination. For human studies, the components of formulations or other mixtures should be identified, but if not available, the source of exposure (i.e. commercial formulation, air pollution, wildfires, hurricanes, and other natural or industrial disasters) should be described as fully as possible.NeuroToxico... welcomes papers describing interventions for mitigating or reversing neurotoxic outcomes, but will accept papers reporting on neuroprotective or neurorestorative properties of formulations, botanical extracts, or other natural products only if full chemical identification and purification information of the active molecule(s) is provided. NeuroToxicology does not accept case reports.
    Subscriptions

  • Current Opinion in Toxicology

    • ISSN: 2468-2020
    Affiliated with the International Union of ToxicologyCurrent Opinion in Toxicology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise, and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Toxicology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Toxicology serves as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Current Opinion in Toxicology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Toxicology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.Division of the subject into sections: For this purpose, the scope of Current Opinion in Toxicology is divided into seven selected, high impact themed sections:Mechanistic ToxicologyMetabolic ToxicologyRisk assessment in ToxicologyGenomic ToxicologySystems ToxicologyTranslatio... ToxicologyGeneral Toxicology (direct submission)Expertise... Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant. Comprehensiveness: There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry. Impact: In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores. Discoverability: Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast, global audience.Selection of topics to be reviewed Editors, who are major authorities in the field, are approved by the Editors-in-Chief of the journal. They divide their sections into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Editors commission reviews from authors on each topic that they have selected and arrange for the peer review process. The papers are reviewed by 2 independent reviewers.Submission... Opinion in Toxicology allows two ways to submit to the journal:Invitation – in accordance with the established procedure for all Current Opinion titles, andDirect submission - authors are invited to submit directly via the submission system Editorial Manager. All submissions are subject to the standard, rigorous peer review by the journal Editors, as well as completeness and relevance check at submission to ensure high quality and research integrity requirements are met. The direct submission papers, if accepted, will be published in the General Toxicology section of the journal.Short ReviewsAuthors are asked to submit short review opinion type articles, in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the 5 years. Original research papers and systematic reviews will not be considered. These can be submitted to the companion journal Current Research in Toxicology.Editorial Overview For invitation only sections, Section Editors write a short overview at the beginning of the section, to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing: General Statement The Editors and the Publisher of this journal believe that there are fundamental principles underlying scholarly and professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper, are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures, if they are believed to be important to readers in judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict.For more information, please refer to: https://www.elsevier...
    Subscriptions

  • Mutation Research: Genetic Toxicology and Environmental Mutagenesis

    • ISSN: 1383-5718
    A section of Mutation ResearchMutation Research: Genetic Toxicology and Environmental Mutagenesis (MRGTEM) publishes papers advancing knowledge in the field of genetic toxicology. Papers are welcomed in the following areas:New developments in genotoxicity testing of chemical agents (e.g., in methodology of assay systems and interpretation of results).Alternative... to and refinement of the use of animals in genotoxicity testing.Nano-genotox... the study of genotoxicity hazards and risks related to novel man-made nanomaterials.Studie... of epigenetic changes in relation to genotoxic effects.The use of structure-activity relationships in predicting genotoxic effects.The isolation and chemical characterization of novel environmental mutagens.The measurement of genotoxic effects in human populations, when accompanied by quantitative measurements of environmental or occupational exposures.The application of novel technologies for assessing the hazard and risks associated with genotoxic substances (e.g., OMICS or other high-throughput approaches to genotoxicity testing).Telomere biology as an endpoint for examination of the effects of chemicals and other environmental exposures.Extracts and complex mixturesAny submissions that report the results of studies on extracts or complex mixtures (e.g., solvent extracts of herbal preparations; soil, air, or water samples) will receive preliminary review by an Editor. Unless such manuscripts offer significant new insight, such as the chemical identification of previously unknown mutagens or anti-mutagens, they will be returned to the authors without being sent for further review. For further clarification of this journal policy please refer to the Editorial published in Mutation Research 391 (1997) 1.MRGTEM is now accepting submissions for a new section of the journal, "Current Topics in Genotoxicity Testing," that will be dedicated to the discussion of current issues relating to design, interpretation, and strategic use of genotoxicity tests. This section is envisaged to include discussions relating to the development of new international testing guidelines, but also to wider topics in the field. The evaluation of contrasting or opposing viewpoints is welcomed as long as the presentation is in accordance with the journal’s aims, scope, and policies.MRGTEM supports and follows the general direction proposed by all major societies in the field part of the International Association of Environmental Mutagenesis and Genomics Societies (IAEMGS):Asociacion Latinoamericana de Mutagenesis, Carcinogenesis y Teratogenesis Ambiental (ALAMCTA)Brazilian Association of Mutagenesis and Environmental Genomics (MutaGen-Brasil)Chin... Environmental Mutagen Society (CEMS)European Environmental Mutagenesis and Genomics Society (EEMGS)Environmental Mutagenesis and Genomics Society (EMGS)Environmental Mutagen Society of India (EMS India)Iranian Environmental Mutagen Society (IrEMS)The Japanese Environmental Mutagen Society (JEMS)Korean Environmental Mutagen Society (KEMS)Molecular and Experimental Pathology Society of Australasia (MEPSA)Pan-African Environmental Mutagen Society (PAEMS)Philippines Environmental Mutagen Society (PEMS)Thai Environmental Mutagen Society (TEMS)Other Mutation Research sections: DNA Repair Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis (MR) Mutation Research - Reviews (MRR)
    Subscriptions

  • Research in Social and Administrative Pharmacy

    • ISSN: 1551-7411
    Widely recognized journal of the International Collaboration of Pharmacy Journal Editors (ICPJE) in comportment with the Granada Statements, Research in Social and Administrative Pharmacy (RSAP) publishes high-quality, peer-reviewed content in health services research specifically as it relates to some aspects of the medication use process. The medication use process includes (but is not limited to) the prescribing, preparation, dispensing, administration, adherence to, evaluation, monitoring, and outcomes associated with legend or with over-the-counter medications, incorporating the concept of clinical pharmacy which optimize utilization of medicines to achieve person-centered and public health goals. The medication use process includes attitudes, perspectives, knowledge, and behaviors of any actor in this process, including prescribers, pharmacists, pharmacy personnel, other health practitioners, patients, and caregivers.In twelve issues per year, RSAP features original scientific reports, comprehensive review articles, proposed models, and provocative commentaries in the social and administrative pharmaceutical sciences.Topics of interest outcomes evaluation of drug products programs, or services pharmacoepidemiology medication adherencedisease managementmedication use policydrug marketingevaluation of educational paradigms that could impact practice and/or patient behaviorother topics related to public health in the context of pharmacy or medication use.RSAP proffers new models to guide existing research, make methodological arguments, or describe the results of rigorous theory-building research. Practice and education research are considered, with preference given to papers evaluating theoretical constructs and to those that might shape policy.The International Collaboration of Pharmacy Journal Editors - ICPJE The ICPJE shares commonalities and goals to improve the medication use process and the outcomes emanating from this endeavor. The ICPJE refers to ‘pharmacy’ as the medication use process. However, research articles, reviews, and commentaries, can refer to any actor involved, as well as any evaluation (e.g. pharmaceoepidemiolog... of the drug products themselves or systems employed, to optimize the use process. Each journal of the ICPJE has an established niche and is optimally suited for certain types of manuscripts.
    Subscriptions

  • Toxicon

    • ISSN: 0041-0101
    Toxicon is affiliated with The Brazilian Society of Toxinology, The International Society on Toxinology and The North American Society of Toxinology.Toxicon is dedicated to all areas related to natural toxins and publishes peer-reviewed manuscripts describing novel findings of broad interest and importance to the toxinology community.Articles that further the understanding and knowledge of toxinology are particularly welcomed, as are review articles on toxinology. Submissions on Toxinology, Pharmacology, Immunology, Biochemistry, Health, Genetics and Molecular Biology are particularly welcomed.The journal publishes articles on the following topics:original research on toxins derived from animals, plants or microorganismsnovel findings related to the chemical, pharmacological, toxicological or immunological properties of natural toxinsmolecular biological studies of toxins and related genes from poisonous and venomous organisms that advance understanding of the role or function of toxinsthe use of toxins as tools in studying biological processesthe translational application of toxins, for example as pharmacological tools, drugs or insecticidesvenom and antivenom issuesclinical observations on poisoning and envenoming where a new therapeutic principle has been proposed or a decidedly superior clinical result has been obtainedepidemiologi... studies on envenoming or poisoning, provided they highlight a previously unrecognized medical problem or provide insight into the prevention or medical treatment of envenoming or poisoningproperly designed prospective community-based surveysToxicon does not accept submissions on: - Retrospective surveys of hospital records, unless species identification is rigorous and the quality of hospital records high. Properly designed prospective clinical studies or community-based surveys are strongly encouraged.- Articles describing activities of venoms or extracts, for example antibacterial, anticancer or analgesic activities, without any attempt to define the mechanism of action or purify the active component.- Bibliometric studies, unless they include a critical evaluation of the field.Toxicon has an open access companion: Toxicon: X. Both journals share the same aims and scope, editorial team, and rigorous peer review. The difference between the journals is the access model under which the journals will publish your work and the indexation status.
    Subscriptions

  • International Immunopharmacology

    • ISSN: 1567-5769
    International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome.The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions. • Studies on the nature and function of drug and hormone receptors on lymphocytes and other cells in the immune system.• Studies of cell-derived or humoral factors that modify the immune system causing cytotoxicity, inducing antibody production and mediating inflammatory responses. • The development of immunologically based assays and their application to disease, including assays for drugs, hormones, cyclic nucleotides, tumor antigens, etc. These Backfiles include Immunopharmacology and the International Journal of Immunopharmacology .International Immunopharmacology does not accept submissions that consist primarily of bioinformatics or computational analyses of public genomic or transcriptomic databases, unless they are supported by experimental studies involving cells, organoids, or experimental animals.
    Subscriptions

  • Regulatory Toxicology and Pharmacology

    • ISSN: 0273-2300
    Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.Types of peer-reviewed articles published:Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:Factors influencing human sensitivityExposure science related to risk assessmentAlternativ... toxicological test methodsFrameworks for evaluation and integration of data in regulatory evaluationsHarmoniza... across regulatory agenciesRead-across methods and evaluationsContempor... Reviews on policy related Research issuesLetters to the EditorGuest Editorials (by Invitation)News on recent or upcoming policy related Research issues, outcomes of regulatory expert meetings with implications for risk assessment and managementRTP Tobacco policyRegulatory Toxicology and Pharmacology, as the journal serving developments for improvement of human health and environment, will not consider manuscripts that have been supported by tobacco companies.
    Subscriptions

Related subjects